Rachel Suzanne Woods, PHD | |
2600 Denali St Ste 450, Anchorage, AK 99503-2754 | |
(907) 561-0552 | |
(907) 561-0562 |
Full Name | Rachel Suzanne Woods |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 2600 Denali St Ste 450, Anchorage, Alaska |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1538640537 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC0700X | Psychologist - Clinical | 135909 (Alaska) | Primary |
Mailing Address | Practice Location Address |
---|---|
Rachel Suzanne Woods, PHD 2600 Denali St Ste 450, Anchorage, AK 99503-2754 Ph: (907) 561-0552 | Rachel Suzanne Woods, PHD 2600 Denali St Ste 450, Anchorage, AK 99503-2754 Ph: (907) 561-0552 |
News Archive
A recent study published online in the Journal of Molecular Diagnostics demonstrated that Droplet Digital PCR technology can be used to detect mutations in a region of our DNA that is linked to many cancer types, paving the way for the development of new cancer diagnostics and therapies.
A new survey from Quality Care for Children shows that the number of child care centers in Georgia declined sharply in 2009 with a net loss of approximately 600 centers while the number of nationally accredited centers dropped roughly 27 percent, from 304 in 2008 to 221 in 2009.
Solazyme, Inc., the renewable oil production company and leader in algal synthetic biology, has been selected by the U.S. Department of Defense (DoD) to research, develop, and demonstrate commercial scale production of algae-derived advanced biofuel that meets the United States Navy's rigorous specifications for military tactical platforms.
It is entirely possible to reduce the salt content in a range of foods by up to 30% without reducing the taste.
EntreMed, Inc. today announced the initiation of a multi-center Phase 2 study with its lead oncology product candidate, ENMD-2076, in patients with platinum resistant ovarian cancer. The study will be conducted at up to six sites in the United States and Canada. In addition, EntreMed received a No Objection Letter (NOL) from the Therapeutic Products Directorate of Health Canada on its Clinical Trial Application to conduct the Phase 2 clinical trial in ovarian cancer patients.
› Verified 2 days ago
James Kyle Timmons, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1020 Potlatch Cir, Anchorage, AK 99503 Phone: 907-947-1862 | |
Raymond Pastorino, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 1201 E 36th Ave, Anchorage, AK 99508 Phone: 907-562-9229 Fax: 907-562-1603 | |
Dr. Sally Schliesmann, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2846 Redwood Pl, Anchorage, AK 99508 Phone: 907-278-1200 Fax: 907-276-3147 | |
Cale Palmer, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3001 C St, Anchorage, AK 99503 Phone: 907-273-4023 | |
Suzette Lewis, PSY. D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1825 Academy Dr, Anchorage, AK 99507 Phone: 907-522-7080 Fax: 907-522-7088 | |
Dennis Gall, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 4050 Lake Otis Pkwy Ste 105, Anchorage, AK 99508 Phone: 907-433-9628 | |
Kelley Russell, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1201 N Muldoon Rd, Anchorage, AK 99504 Phone: 907-257-4700 |